PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

(-)-Epigallocatechin-3-gallate, reduces corneal damage secondary from experimental grade II alkali burns in mice.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30600126 ↗2019Reported benefit

(-)-Epigallocatechin-3-gallate, reduces corneal damage secondary from experimental grade II alkali burns in mice.

MouseChemical/toxinTopical ocular instillation10 microMAfter burn, in the acute phase

Model: Experimental grade II corneal alkali burn

Topical epigallocatechin-3-gallate reduced corneal opacity, neovascularisation, oedema and inflammation and normalised epithelial morphology after alkali burn.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.